BioAgilytix Welcomes Dominic Marasco to Leadership Team as Chief Commercial Officer

The Latest News from BioAgilytix

November 4, 2019

BioAgilytix Announces Acquisition of Boston-Based Clinical Research Organization Cambridge Biomedical

Cambridge Biomedical, a contract research organization based in the Cambridge area of Massachusetts, also specializes in large molecule bioanalysis. The transaction expands BioAgilytix’s global footprint into the heart of the world’s major biotech center, and adds further capacity by joining Cambridge Biomedical’s CLIA-certified, CAP-accredited, and GLP-compliant facility with its GxP laboratories in Durham, North Carolina and Hamburg, Germany.

Read More

October 22, 2019

BioAgilytix Receives Certificate of Registration from CLIA

BioAgilytix has received its Certificate of Registration from the Clinical Laboratory Improvement Amendments (CLIA) program regulated by the Centers for Medicare & Medicaid Services (CMS) for its U.S. facility in Durham, NC. The CLIA certificate confirms that BioAgilytix is now able to perform lab-developed tests in the diagnostic immunology specialty that are deemed “high complexity” and subject to CLIA oversight.

Read More

October 14, 2019

BioAgilytix Named a Triangle Business Journal Fast 50 Winner for 2019

BioAgilytix has been named by Triangle Business Journal as a Fast 50 Award winner for 2019, marking the seventh time the organization has been recognized as one of the fastest growing privately held companies in the Triangle Park area.

Read More

August 15, 2019

Thomas Zajkowski Joins BioAgilytix Leadership Team as Chief Financial Officer

Mr. Zajkowski brings more than 25 years of experience managing finance functions in private equity-sponsored and publicly-traded companies, including multiple healthcare and life sciences organizations.

Read More

August 14, 2019

BioAgilytix Named to Inc. Magazine’s Inc. 5000 List of Fastest-Growing Private U.S. Companies for Sixth Time

BioAgilytix has been named to Inc. Magazine’s Inc. 5000 list of the fastest-growing private companies in America for 2019: its sixth appearance on the list in the last seven years.

Read More

July 9, 2019

BioAgilytix Completes New Campus Expansion at Its USA Headquarters

BioAgilytix has completed the latest expansion of its Durham, NC campus, which serves as the company’s USA headquarters, with the opening of an additional 21,173 square foot building directly adjacent to its existing facility.

Read More

June 11, 2019

BioAgilytix Welcomes Sean Blake to Leadership Team as Chief Information Officer

In this role, Mr. Blake will lead the development, assessment, and execution of critical IT strategies across BioAgilytix’s international operations to support the company’s continued growth and position as a technologically-advanced bioanalytical services provider.

Read More

March 26, 2019

BioAgilytix Announces Promotion of Corinna Fiorotti, Ph.D. to Scientific Officer and Key Accounts Director

BioAgilytix has announced that Corinna Fiorotti, Ph.D., has been promoted to Scientific Officer and Key Accounts Director for the company, and will take a leading role in developing and managing customer accounts throughout North America.

Read More

February 7, 2019

BioAgilytix Welcomes Lydia Michaut, Ph.D. to Team as Scientific Officer

BioAgilytix has welcomed Lydia Michaut, Ph.D. to its team as Scientific Officer. Dr. Michaut will be based in BioAgilytix Europe’s laboratory in Hamburg, Germany and will play an integral role in the oversight of its bioanalytical teams as well as project strategies. Dr. Michaut brings more than 25 years of experience in fundamental research and clinical development, including work in two award-winning academic laboratories.

Read More

January 1, 2019

BioAgilytix Announces Several Promotions within Its Leadership Team

BioAgilytix has announced several promotions within its leadership team. PD Dr. Arno Kromminga has been promoted to Global Chief Scientific Officer, and will lead BioAgilytix’s global scientific strategy while also continuing to serve as the European Managing Director. Beth Heinz has been promoted to Vice President of Global Business Development and will continue her focus on cultivating and managing both strong client relationships and strategic partnerships worldwide.

Read More